Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage

被引:56
作者
Ducruet, Andrew F. [1 ]
Hickman, Zachary L. [1 ]
Zacharia, Brad E. [1 ]
Grobelny, Bartosz T. [1 ]
DeRosa, Peter A. [1 ]
Landes, Elissa [1 ]
Lei, Shuang [1 ]
Khandji, Joyce [1 ]
Gutbrod, Sarah [1 ]
Connolly, E. Sander, Jr. [1 ]
机构
[1] Columbia Univ, Dept Neurol Surg, New York, NY 10032 USA
关键词
Antiplatelet agents; intracerebral hemorrhage; platelets; CEREBRAL-HEMORRHAGE; TIME-COURSE; ASPIRIN-USE; ENLARGEMENT; GROWTH; CLOPIDOGREL; INHIBITION; PREDICTORS; MORTALITY; THERAPY;
D O I
10.1179/174313209X459129
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Patients receiving antiplatelet medications are reported to be at increased risk for hematoma enlargement and worse clinical outcomes following intracerebral hemorrhage (ICH). While platelet transfusions are frequently administered to counteract qualitative platelet defects in the setting of ICH, conclusive evidence in support of this therapeutic strategy is lacking. In fact, platelet transfusions may be associated with adverse effects, and represent a finite resource. We sought to determine the clinical efficacy of platelet transfusion and its impact on systemic complications following ICH in a cohort of patients receiving antiplatelet medications. Methods: We retrospectively analysed the medical records of 66 patients admitted to our institution from June 2003 to July 2008 who suffered a primary ICH while receiving antiplatelet (acetylsalicylic acid and/or clopidogrel) therapy. The primary outcome was the rate of significant (>25% increase from admission) hematoma expansion in transfused (n=535) versus non-transfused (n=531) patients. Discharge modified-Rankin score (mRS) and the rates of systemic complications were also assessed. Results: There were no statistically significant differences in rates of hematoma expansion between cohorts, nor were there differences in demographic variables, systemic complications or discharge mRS. Subgroup analysis revealed that there was a higher rate of hematoma expansion in the clopidogrel cohort (p=0.034) than in the cohort of patients receiving aspirin alone. Discussion: This study suggests that platelet administration does not reduce the frequency of hematoma expansion in ICH patients receiving antiplatelet medications. This lack of efficacy may relate to transfusion timing, as a significant proportion of hematoma expansion occurs within 6 hours post-ictus. Additionally, the increased rates of hematoma expansion in the clopidogrel cohort may relate to its prolonged half-life. A larger, prospective study is warranted.
引用
收藏
页码:706 / 710
页数:5
相关论文
共 26 条
[1]   Guidelines for the management of spontaneous intracerebral Hemorrhage in adults - 2007 update - A guideline from the American Heart Association/American Stroke Association Stroke Council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group - The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. [J].
Broderick, Joseph ;
Connolly, Sander ;
Feldmann, Edward ;
Hanley, Daniel ;
Kase, Carlos ;
Krieger, Derk ;
Mayberg, Marc ;
Morgenstern, Lewis ;
Ogilvy, Christopher S. ;
Vespa, Paul ;
Zuccarello, Mario .
STROKE, 2007, 38 (06) :2001-2023
[2]   Determinants of intracerebral hemorrhage growth - An exploratory analysis [J].
Broderick, Joseph P. ;
Diringer, Michael N. ;
Hill, Michael D. ;
Brun, Nikolai C. ;
Mayer, Stephan A. ;
Steiner, Thorsten ;
Skolnick, Brett E. ;
Davis, Stephen M. .
STROKE, 2007, 38 (03) :1072-1075
[3]   INTRACEREBRAL HEMORRHAGE MORE THAN TWICE AS COMMON AS SUBARACHNOID HEMORRHAGE [J].
BRODERICK, JP ;
BROTT, T ;
TOMSICK, T ;
MILLER, R ;
HUSTER, G .
JOURNAL OF NEUROSURGERY, 1993, 78 (02) :188-191
[4]   Early hemorrhage growth in patients with intracerebral hemorrhage [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
Barsan, W ;
Tomsick, T ;
Sauerbeck, L ;
Spilker, J ;
Duldner, J ;
Khoury, J .
STROKE, 1997, 28 (01) :1-5
[5]  
Caplain H, 1999, SEMIN THROMB HEMOST, V25, P25
[6]   Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage [J].
Caso, Valeria ;
Paciaroni, Maurizio ;
Venti, Michele ;
Alberti, Andrea ;
Palmerini, Francesco ;
Milia, Paolo ;
Billeci, Antonia M. R. ;
Silvestrelli, Giorgio ;
Biagini, Sergio ;
Agnelli, Giancarlo .
CEREBROVASCULAR DISEASES, 2007, 24 (2-3) :215-218
[7]   PROGRESSION OF HYPERTENSIVE INTRACEREBRAL HEMORRHAGE [J].
CHEN, ST ;
CHEN, SD ;
HSU, CY ;
HOGAN, EL .
NEUROLOGY, 1989, 39 (11) :1509-1514
[8]   PHARMACOLOGY OF PLATELET INHIBITION IN HUMANS - IMPLICATIONS OF THE SALICYLATE-ASPIRIN INTERACTION [J].
DEGAETANO, G ;
CERLETTI, C ;
DEJANA, E ;
LATINI, R .
CIRCULATION, 1985, 72 (06) :1185-1193
[9]  
DENNIS MS, 2003, CEREBROVASC DIS, V16, pS9
[10]   Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage [J].
Foerch, Christian ;
Sitzer, Matthias ;
Steinmetz, Helmuth ;
Neumann-Haefelin, Tobias .
STROKE, 2006, 37 (08) :2165-2167